Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (141-150 of 385) with videos related to

Pageof 39
Sort By:
Frontiers in Immunology|October 18, 2021
CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell TransplantationClarissa Heck, Sophie Steiner, Eva M Kaebisch, et al.
Hemasphere|February 24, 2021
NEMHESYS-European Perspective on the Implementation of Next-generation Sequencing Into Clinical DiagnosticsInmaculada Serramito-Gómez, Kathryn M Clarke, Ana Eugenia Rodríguez-Vicente, et al.
The New England Journal of Medicine|May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemiaRichard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Haematologica|June 5, 2014
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemiaHaiyang Yun, Frederik Damm, Damian Yap, et al.
International Journal of Cancer|October 17, 2024
Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysisAnnika Strönisch, Daniel Rau, Silvan Wittenberg, et al.
Frontiers in Immunology|June 9, 2022
Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network ApproachFriedrich Wittenbecher, Stella Lesch, Stefan Kolling, et al.
Haematologica|October 15, 2020
The long non-coding RNA <i>Cancer Susceptibility 15</i> (<i>CASC15</i>) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemiaSarah Grasedieck, Christoph Ruess, Kathrin Krowiorz, et al.
Journal of Geriatric Oncology|November 23, 2020
Clinical outcome of older adults with acute myeloid Leukemia: An analysis of a large tertiary referral Center over two decadesJana Ihlow, Sophia Gross, Nina Rosa Neuendorff, et al.
Gut Microbes|May 31, 2022
Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphomaMaren Schmiester, René Maier, René Riedel, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Pageof 39

Showing results (141-150 of 385) with videos related to

Sort By:
Pageof 39
Frontiers in Immunology|October 18, 2021
CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell TransplantationClarissa Heck, Sophie Steiner, Eva M Kaebisch, et al.
Hemasphere|February 24, 2021
NEMHESYS-European Perspective on the Implementation of Next-generation Sequencing Into Clinical DiagnosticsInmaculada Serramito-Gómez, Kathryn M Clarke, Ana Eugenia Rodríguez-Vicente, et al.
The New England Journal of Medicine|May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemiaRichard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Haematologica|June 5, 2014
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemiaHaiyang Yun, Frederik Damm, Damian Yap, et al.
International Journal of Cancer|October 17, 2024
Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysisAnnika Strönisch, Daniel Rau, Silvan Wittenberg, et al.
Frontiers in Immunology|June 9, 2022
Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network ApproachFriedrich Wittenbecher, Stella Lesch, Stefan Kolling, et al.
Haematologica|October 15, 2020
The long non-coding RNA <i>Cancer Susceptibility 15</i> (<i>CASC15</i>) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemiaSarah Grasedieck, Christoph Ruess, Kathrin Krowiorz, et al.
Journal of Geriatric Oncology|November 23, 2020
Clinical outcome of older adults with acute myeloid Leukemia: An analysis of a large tertiary referral Center over two decadesJana Ihlow, Sophia Gross, Nina Rosa Neuendorff, et al.
Gut Microbes|May 31, 2022
Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphomaMaren Schmiester, René Maier, René Riedel, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Pageof 39